Browse by Poster Presenter

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

M
M. Helmy, Abdelrahman

Deraya University
(T1030-05-26) 3D-Printed Short Nanofibers/Hydrogel-Based Vaginal Films as a Novel System for the Delivery of Anti-HIV Microbicide Drugs
Abdelrahman M. Helmy
Favorite
Müller-Ranft, Beat

Coperion K-tron
(T1330-10-54) Continuous Manufacturing: Rheological Powder Characterisation of Excipients to Understand Their Behaving during the Feeding Step
Beat Müller-Ranft
Favorite
Müllertz, Anette

Copenhagen University
(M0930-07-37) Enabling Oral Delivery of Therapeutic Peptide Salmon Calcitonin: Impact of Hydrophobic Ion Pairs and Self-Nanoemulsifying Drug Delivery Systems on Proteolytic Protection and Pharmacological Activity
Anette Müllertz
Favorite
(M1530-10-58) In Vivo Bioavailability Enhancement of Abiraterone Acetate Dispersome^® Formulations
Anette Müllertz
Favorite
(T1230-07-40) Evaluating the Gastric Integrity of Capsugel® Enprotect® Capsules in Fasted and Fed State Using the Dynamic Gastric Model (DGM)
Anette Müllertz
Favorite
(W0930-09-51) Evaluating Formulation Platforms for Poorly Soluble APIs to Mimic PROTACs
Anette Müllertz
Favorite
Macedo, Joana

Xedev
(T1330-03-15) Optimization of Spray-Dried Amorphous Solid Dispersions (ASDs) for Capsule Administration
Joana Macedo
Favorite
(W0930-03-15) Spray Drying of Directly Compressible Amorphous Solid Dispersions (ASDs): Comparison of Different Polymers
Joana Macedo
Favorite
MacKay, J. Andrew

University of Southern California
(M1030-04-20) A Physiologically Based Pharmacokinetic Model of ¹⁸F-FMAU to Accompany Positron Emission Tomography in Humans
J. Andrew MacKay
Favorite
(M1030-07-37) GRP78 Targeting of Long-Acting Hydra-Elastin-Like Polypeptides (ELPs) Carrying Rapamycin to Breast Cancer
J. Andrew MacKay
Favorite
Magsombol-Karaan, Mary

Dow Development Laboratories, LLC
(M1330-09-49) Eliminating Operator Dependence from Gelling Agent Addition - Improving the Robustness and Processing Time of Semi-Solid Dosage Forms Without Impacting the Viscosity or Aesthetics
Mary Magsombol-Karaan
Favorite
(W0930-09-50) Determining the Most Suitable Gelling Agent for Topical Semi-Solid Formulation Development- An Investigation into the Physical Robustness of Various Gelling Agents
Mary Magsombol-Karaan
Favorite
(W1030-07-40) Using Gravitational Force to Determine the Minimum Concentration of Various Gelling Agents Needed to Maintain Homogeneity of Micronized API in Suspension
Mary Magsombol-Karaan
Favorite
Mahady, Gail

University of Illinois Chicago
(M1430-02-08) Transcriptomic Analysis Reveals that Nymphaea odorata Extracts and Fractions Upregulate the Apoptosis, Autophagy, and Unfolded Protein Canonical Pathways in MCF-7 Cells
Gail Mahady
Favorite
Mahanta, Sailendra

Assam Kaziranga University
(W1030-04-19) Beyond Voltage-Gated Sodium Channel (Na_v1.7): Exploring the Dual Role of GX201 and Sulfamethoxazole in Itch Management
Sailendra Mahanta
Favorite
Mahant, Shweta

PPD Laboratories
(M1130-06-34) Comparison of Platform Sensitivities: Correlation of Endogenous Neurofilament-Light Chain Concentration Determination in Human Serum and K₂EDTA Plasma across Immunoassay Platforms
Shweta Mahant
Favorite
Mahato, Ram

University of Nebraska Medical Center
(M1030-05-26) Co-Administration of a Novel Hedgehog Inhibitor and Anti-miR-96 in a Lipid-Based Nanosystem for the Treatment of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)
Ram Mahato
Favorite
(M1430-04-23) Combination Therapy of BRD4/PI3K Dual Inhibitor and a Novel Hedgehog Inhibitor for the Treatment of Sonic Hedgehog and MYC-Amplified Medulloblastoma
Ram Mahato
Favorite
Mahato, Sohan

University of Nebraska Medical Center
(M1030-05-26) Co-Administration of a Novel Hedgehog Inhibitor and Anti-miR-96 in a Lipid-Based Nanosystem for the Treatment of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)
Sohan Mahato
Favorite
Mahlmeister, Christian

Evonik Nutrition & Care GmbH
(M1530-03-17) Downstreaming Amorphous Solid Dispersions: Direct Compression of Free-Flowing Telmisartan Microparticles
Christian Mahlmeister
Favorite
Mahmoudi, Morteza

Michigan State University
(W1230-01-03) Cellular Uptake of Bare and Corona Coated PEO-b-PCL and PEO-b-PBCL Micelles by HCT116 and SW620 Cell Lines
Morteza Mahmoudi
Favorite
Mahmoudi, Zahra

International Flavors and Fragrances
(M1430-01-04) Formulation and In Vitro Evaluation of Carrageenan Based Gummies
Zahra Mahmoudi
Favorite
(T1230-05-26) Low Nitrite-Controlled Release Formulations for Water-Soluble Drugs
Zahra Mahmoudi
Favorite
Mahnen, Cory

Ashland Specialty Ingredients
(M1130-09-52) Inclusion Complexes of Posaconazole with Hydroxypropyl- and Sulfobutylether-β-Cyclodextrins for Intravenous Injections: Formulation and Stability Studies
Cory Mahnen
Favorite
(M1430-03-14) Intravitreal Delivery of Anti-Inflammatory Agents via Thermo-Responsive Gel-Forming Biodegradable Triblock Copolymers
Cory Mahnen
Favorite
(T1330-01-01) Use of Thermo-Responsive Biodegradable Triblock Copolymers in Design of a Novel Delivery Formulation for Intravitreal Injection of Pirfenidone
Cory Mahnen
Favorite
(T1530-03-14) Importance of β Cyclodextrin Substitution Level and Type for Solubilization and Stabilization of Poorly Soluble APIs in Parenteral Dosage Forms
Cory Mahnen
Favorite
(W1130-03-13) Powerful Tools for Precise Engineering of Viatel^TM Diblock Nanoparticle Size: Polymer and Solvent Structure
Cory Mahnen
Favorite
Mahto, Sohan

University of Nebraska Medical Center
(M1430-04-23) Combination Therapy of BRD4/PI3K Dual Inhibitor and a Novel Hedgehog Inhibitor for the Treatment of Sonic Hedgehog and MYC-Amplified Medulloblastoma
Sohan Mahto
Favorite
Maienschein-Cline, Mark

University of Illinois Chicago
(M1430-02-08) Transcriptomic Analysis Reveals that Nymphaea odorata Extracts and Fractions Upregulate the Apoptosis, Autophagy, and Unfolded Protein Canonical Pathways in MCF-7 Cells
Mark Maienschein-Cline
Favorite
Maier, Esther

Drug Dynamics Institute
(M1030-03-13) Cationic Peptide Anchor-Mediated Binding to Tumor Extracellular Matrix Improves Intratumoral Retention of Agonist CD40 Antibody
Esther Maier
Favorite
(T1330-09-49) In Vivo and Biopredictive In Vitro Dissolution Testing of Dexamethasone Intravitreal Implants in Rabbits
Esther Maier
Favorite
Maisum Sarwar, Jyoti Md

Sunsho Pharmaceuticals Co; Ltd
(W1030-09-50) Development of Colon-Targeting UniORV Containing Salazosulfapyridine Composed of Chitosan/Alginate-Based Matrix
Jyoti Md Maisum Sarwar
Favorite
Maithania, Heena

Frontage Laboratories, Inc.
(W0930-03-13) Evaluating the Feasibility of Lyophilization for Oral Formulation Development of Monoclonal Antibodies (mAbs)
Heena Maithania
Favorite
Maitra, Prithwiraj

Allergan Aesthetics Skincare R&D
(T1430-01-04) Exploration of Antioxidant Activity and Conversion Potential of Cosmeceutical Actives: Ascorbic Acid and Its Derivatives
Prithwiraj Maitra
Favorite
Ma, Jennifer

Frontage Laboratories, Inc.
(T1330-06-36) A GxP-Qualified dPCR-Based RCL Assay to Quantify Replication Competent Lentivirus in Bioanalytical Samples
Jennifer Ma
Favorite
Ma, Jian-Xing

Wake Forest University
(T1030-03-14) Novel Microemulsion-Based Fenofibrate Eyedrop for Treating Nitrogen Mustard-Induced Corneal Injury
Jian-Xing Ma
Favorite
(T1430-07-41) Fenofibrate Microparticles for Long Lasting Therapy of Posterior Eye Disease
Jian-Xing Ma
Favorite
Majima, Toshiyoi

Developing Virtue Secondary Schools
(T1230-03-13) Enhancement of Transdermal Delivery for β-Carotene as a Treatment of Skin Cancer: Quality by Design Optimization of Microemulsion Formulation
Toshiyoi Majima
Favorite
Majumdar, Soumyajit

University of Mississippi
(T1330-07-38) Impact of Oleic Acid Based Nanoemulsions on Corneal Integrity: An Ex Vivo Study Using Rabbit Corneas
Soumyajit Majumdar
Favorite
(T1530-07-39) Overcoming Incompatibility between Moxifloxacin and Carbopol^®934 Polymers in Ophthalmic Drug Delivery Systems
Soumyajit Majumdar
Favorite
(W0930-07-39) Development and Characterization of Cannabidiol and Rho Kinase Inhibitor Combination Formulations for Ophthalmic Use
Soumyajit Majumdar
Favorite
Majumder, Sushmita

University of Minnesota
(T1030-04-22) Structure-Mechanical Property Relationship in Molecular Crystals for Predicting Tabletability
Sushmita Majumder
Favorite
Makabe, Muneyoshi

Daiichi Sankyo Co., Ltd.
(T1230-10-54) Validation of the Potential of Oligoarginine-Linked Hyaluronic Acid as an Absorption Enhancer Through Animal Studies from Rodents to Primates
Muneyoshi Makabe
Favorite
Makary, Moheb

US Food and Drug Administration
(T0930-10-56) Current Drug Substance Stability Issues Related to the Biopharmaceutics Classification System (BCS) Class III -Based Biowaivers in Abbreviated New Drug Applications (ANDAs)
Moheb Makary
Favorite
Maki, Koichiro

Osaka Medical and Pharmaceutical University
(M1230-03-15) Coamorphous Nanoparticles Produced by Co-precipitation of Two Drugs Based on Liquid-Liquid Phase Separation: Improved Solubility and Membrane Permeability
Koichiro Maki
Favorite
Makishima, Takashi

Astellas Pharma Inc.
(T1030-10-59) Unexpected Nucleation of Amorphous Terfenadine at a Much Lower Temperature than the Glass Transition Temperature and Its Impact on Dissolution Behavior and Physical Stability
Takashi Makishima
Favorite
Malavia, Nileshkumar

University of Connecticut
(M1130-04-20) Impact of Macrophages on the Dissolution of Long-Acting Injectable Suspensions
Nileshkumar Malavia
Favorite
Ma, Lisa

DigiM Solution LLC
(M1530-11-60) Impact of X-Ray Micro-CT Resolution on Quantification of Quality Attributes and Simulated Mass Transport Properties of Lyophilized Products
Lisa Ma
Favorite
(W1130-10-57) Assessing Topical Dosage Form Manufacturing Methods and Their Impact on Globule Microstructure with Non-Invasive Micro-CT Analysis
Lisa Ma
Favorite
Mallik, Sanku

North Dakota State University
(T1330-01-03) Development of Hypoxia-Responsive Polymersomes for Drug Delivery to Pancreatic Ductal Adenocarcinoma (PDAC) Cells
Sanku Mallik
Favorite
(W1030-07-39) Mesenchymal Stem Cell-Based Combination Therapy for Enhanced Efficacy Against Patient-Derived Lung Cancer Xenograft Model
Sanku Mallik
Favorite
(W1230-01-06) Peptide Conjugated Hypoxia-Responsive Nanoparticles to Decrease Triple-Negative Breast Cancer Stemness in a Patient-Derived Xenograft Mice Model
Sanku Mallik
Favorite
Maloney Norcross, Sara

RTI International
(M0930-03-16) Optimizing Storage Conditions to Maintain Chemical Stability and Aerodynamic Performance of Tigecycline Inhalation Powder
Sara Maloney Norcross
Favorite
Maloney, David

Veralox Therapeutics, Inc.
(W0930-02-11) VLX-1005 Multiple Ascending Dose Pharmacokinetics
David Maloney
Favorite
MANCINI, VANESSA

InnoGI Technologies
(T1230-10-57) Biorelevant Dissolution Testing in Tiny-TIMsg to Improve Predictivity of Food Effect on Oral Delivery of BCS Class II Compound
VANESSA MANCINI
Favorite
(W1130-07-40) Integrating Bioaccessibility Data from the Tiny-TIMsg into a Physiologically Based Biopharmaceutics Model (PBBM) of a BCS Class IV Compound to Predict Pharmacokinetic (PK) Performance
VANESSA MANCINI
Favorite
Mandal, Bivash

GlaxoSmithKline plc
(W1130-11-62) Evaluation of Ice Nucleation/Freezing Phenomenon for a Monoclonal Antibody Drug Product Solution in Primary Container Closure Systems Using a Thermal Cycling Chamber
Bivash Mandal
Favorite
Mandavalli, Shweta

Amgen Inc.
(M0930-10-58) Protein Engineering Strategies to Overcome High Target-Independent Clearance of Monoclonal Antibodies Due to Charge-Driven Liabilities
Shweta Mandavalli
Favorite
Manickam, Devika

Duquesne University
(W1130-03-17) Re-engineering of Lipid Nanoparticles Using Ionic Liquids for Brain Drug Delivery
Devika Manickam
Favorite
Maniruzzaman, Mohammed

University of Mississippi
(M1030-09-49) Selective Laser Sintering 3D Printing for Improved Solubility of Indomethacin: A Study on Amorphous Drug Conversion
Mohammed Maniruzzaman
Favorite
(M1030-10-55) Factory-on-a-Pill – a Digital Pill Concept to Deliver Medicines in Space
Mohammed Maniruzzaman
Favorite
(M1430-09-50) Creating Personalized 3D-Printed Finger Splints with Ibuprofen-Loaded Nanofibers for Quicker Healing Using CT Scans
Mohammed Maniruzzaman
Favorite
(M1530-07-37) Optimization of 3D Printed Tablets Using Artificial Intelligence and Machine Learning
Mohammed Maniruzzaman
Favorite
(T1030-05-26) 3D-Printed Short Nanofibers/Hydrogel-Based Vaginal Films as a Novel System for the Delivery of Anti-HIV Microbicide Drugs
Mohammed Maniruzzaman
Favorite
(T1130-07-41) Novel 3D Printed Polypill for Diabetes Mellitus Management and Associated Cardiovascular Risks
Mohammed Maniruzzaman
Favorite
(T1330-09-50) Exploratory Studies of Curcumin Loaded PCL Microparticles Produced Using a Novel Technology- SMART
Mohammed Maniruzzaman
Favorite
(T1530-10-55) 3D Printed Container System for Delayed Release
Mohammed Maniruzzaman
Favorite
(W1230-09-49) Optimization of Ocular Mini Tablet Formulations: A Comparative Study of 3D FDM Printing and Vacuum Compression Molding Methods for Sustained Drug Release
Mohammed Maniruzzaman
Favorite
(W1230-11-63) A Novel First-in-Class 3D Printing Technology for Advanced Manufacturing of Complex Vaccine Formulations against Influenza and Emerging Infectious Diseases
Mohammed Maniruzzaman
Favorite
Manthena, Sweta

Pfizer Inc.
(W1230-07-40) Expanding the Design Space of Swellable Core Technology (SCT) for Delivery of Higher Doses and Patient Centric Dosage Form
Sweta Manthena
Favorite
Mao, Chen

Genentech, Inc.
(T1230-11-61) Reaching an Optimum Calibration-Free Solution: The Role of Numerical Solver Parameters on IOT Prediction of Active Ingredients in Pharmaceutical Powder Blends
Chen Mao
Favorite
Mao, Dake

Bristol-Myers Squibb Company
(W1130-10-54) Streamlining Pharmaceutical Process Development: A User-Centric Approach to High-Throughput Analysis
Dake Mao
Favorite
Mao, Yuxia

Pfizer Inc.
(M1530-09-52) Mass Transport Modeling and In Silico Formulation of Osmotic Controlled Release Tablets with Microscopy-Based Digital Twins
Yuxia Mao
Favorite
(W1130-09-52) Insights in Designing Osmotic Modified Release Delivery Platform for Solid Dispersions: Challenges and Conception
Yuxia Mao
Favorite
(W1230-07-40) Expanding the Design Space of Swellable Core Technology (SCT) for Delivery of Higher Doses and Patient Centric Dosage Form
Yuxia Mao
Favorite
Maqsood, Iram

University of Maryland Baltimore
(T1130-05-29) Sodium Alginate-Based Bio-Adhesive Hydrogel: A Hemostatic Agent, Endoscopically Deliverable to the Gastrointestinal Resection Site
Iram Maqsood
Favorite
(T1230-01-06) A Novel Approach Using an Organic Phase Nanosuspension to Enhance Drug Loading of Hydrophilic Compounds in Nanoparticles
Iram Maqsood
Favorite
Mara, Nathan

University of Minnesota
(T1030-04-22) Structure-Mechanical Property Relationship in Molecular Crystals for Predicting Tabletability
Nathan Mara
Favorite
Marchant, María

Pontificia Universidad Catolica de Chile de valparaíso
(M1030-04-23) Formulation of a Triple-Action Nanoemulgel for Mild to Moderate Atopic Dermatitis: Impact on Skin's Mechanical and Antibacterial Properties
María Marchant
Favorite
Mares, Pavel

Academy of Sciences of the Czech Republic
(M0930-01-05) Lipid-Stabilized Nanocrystal Vesicles for Cheat-Free Testing of Novel Drugs: The Case of Zuranolone
Pavel Mares
Favorite
Marino, Giorgio

Corden Pharma
(M1030-11-63) Investigation of Interplay between API Processing Method and Modified Release Matrix Tablet on Dissolution Performance
Giorgio Marino
Favorite
Markovski, Roza

IMCD
(T1430-11-63) Advancements in Sustainable Moisture Activated Dry Granulation: Optimizing Excipients and Process for Diosmin 500 mg Tablet Formulation
Roza Markovski
Favorite
Markus, Tiffany

Spheryx, Inc.
(M1030-11-60) Detecting and Identifying Contaminants for Root Cause Analysis: Distinguishing Free Fatty Acid Breakdown Products of Surfactants, Silicone Oil and Protein Aggregates
Tiffany Markus
Favorite
Maroney Lawrence, Yen

Texas Southern University
(T1330-09-48) Controllable Microfluidic Synthesis of Drug-Loaded PLGA/PEG Nanoparticles Using DoE Approaches with Versatile Flow Streams
Yen Maroney Lawrence
Favorite
Marques, Luís

Hovione
(T0930-05-27) Improving Lipid Nanoparticles Stability for mRNA Lung Delivery Through Nebulization
Luís Marques
Favorite
(T1230-07-38) Protein Stabilization Sweet Spot: Novel Class of Sugar-Based Excipients Enabling Downstream Processing and Formulation
Luís Marques
Favorite
Marsh, Josh

Lonza
(W1030-09-51) Early-Phase Form Screening of Solubility-Limited Drugs Via In Vitro Characterization and In Silico Modeling
Josh Marsh
Favorite
Martin, Charlie

Leistritz Extrusion
(T1030-11-63) Twin Screw Extrusion Process Design and Die Modeling for Directly Extruded Implants
Charlie Martin
Favorite
Martinez-Acevedo, Lizbeth

Metropolitan Autonomous University
(M1330-03-17) Development, Characterization, and In Vitro Digestion of C-phycocyanin-Whey Protein Isolate-Zein Nanoparticles for Pharmaceutical Applications
Lizbeth Martinez-Acevedo
Favorite
(W1030-01-05) Sustainable Development of a Nanosystem for the Co-encapsulation of Apigenin and Curcumin for Pharmaceutical Applications
Lizbeth Martinez-Acevedo
Favorite
Martin, Lawrence

Colorcon
(T1230-01-02) Effect of Mixing Time and Mixing Process on Lubricant Sensitivity of Excipients with Different Deformation Characteristics
Lawrence Martin
Favorite
(W1230-10-54) Development of Robust and Customizable Zero-Order Release Push-Pull Osmotic Tablets
Lawrence Martin
Favorite
Martin, Stephen

University of Texas
(W1130-01-01) Development of an Intraocular In Situ-Forming Implant of a Novel Compound to Target the Retina in a Rabbit Model
Stephen Martin
Favorite
Mashinson, Viktoriya

University of Nebraska Medical Center
(M1230-04-23) Design, Synthesis, and Evaluation of Claudin-1 Inhibitors for the Treatment of Metastatic Colorectal Cancer
Viktoriya Mashinson
Favorite
Masih, Shabkhaiz

Genentech, Inc
(M1130-02-10) Bivariate Statistical Analyses Reveal the Performance of Human FcRn Transgenic Mouse in Predicting Human Pharmacokinetics of Therapeutic Antibodies
Shabkhaiz Masih
Favorite
Masoudzadeh, Farnoush

Abzena
(M1530-06-36) Platform Approach for Identifying the Most Functional and Developable Bispecific T Cell Engager
Farnoush Masoudzadeh
Favorite
Massard, Sebastien

Vantage Specialty Chemicals
(M1230-07-41) Investigation of the Dermal Delivery of Benzoyl Peroxide from Topically Applied Formulations In Vitro
Sebastien Massard
Favorite
Masum, Zia Uddin

St. John's University
(T1330-03-17) Developing Biosustane SAIB NF as a Novel Excipient for Oral Dosage Forms
Zia Uddin Masum
Favorite
Matadh, Anusha

IDBR
(M1530-06-35) Formulation and Evaluation of Antibacterial Activity of K21 Topical Liquid and Gel Formulations
Anusha Matadh
Favorite
Matahira, Yoshiharu

Sunsho Pharmaceutical Co., Ltd.
(W1030-09-50) Development of Colon-Targeting UniORV Containing Salazosulfapyridine Composed of Chitosan/Alginate-Based Matrix
Yoshiharu Matahira
Favorite
Mateen, Sameena

Idaho State University
(W0930-03-16) Comparative Bioavailability Study of Jaspine B: Impact of Nano-Liposomal Drug Delivery System on Pharmacokinetics
Sameena Mateen
Favorite
Mateti, Kranthi

Kenox Pharmaceutical Inc.
(M1430-09-52) Development of Dry Powder Formulation of PAV-104 for Pulmonary Drug Delivery
Kranthi Mateti
Favorite
Mathis, Amanda

BioCryst
(M1230-02-10) No Clinically Meaningful Pharmacokinetic Drug-Drug Interaction Between Berotralstat and the Progestin Oral Contraceptive Desogestrel
Amanda Mathis
Favorite
Matters, Gail

Pennsylvania State University
(T1330-06-32) Bombesin-Tagged Nanobubbles as Ultrasound Contrast Agents for Prostate Cancer Diagnosis
Gail Matters
Favorite
Maul, Elise

University of Kentucky
(T0930-02-10) PK/PD Relationship of a Promising Protein Drug Candidate (CocH5-Fc(M6)) and Its Efficacy in Blocking Cocaine Discrimination in Rats
Elise Maul
Favorite
Maurus, Kellen

University of Connecticut
(M1130-04-20) Impact of Macrophages on the Dissolution of Long-Acting Injectable Suspensions
Kellen Maurus
Favorite
Mavroudis, Panteleimon

Sanofi
(T0930-10-57) Predicting Pharmacokinetic Response of Small Molecules in Rats via Machine Learning
Panteleimon Mavroudis
Favorite
Maxwell, Julia

Lonza
(W1030-09-51) Early-Phase Form Screening of Solubility-Limited Drugs Via In Vitro Characterization and In Silico Modeling
Julia Maxwell
Favorite
Mazzola, Priscila

University of Campinas
(M1130-01-03) Exploring the Pharmacological Properties of Spondias mombin L. Seed Extract
Priscila Mazzola
Favorite
(M1330-05-27) Design of Foamable Microemulsions for Vaginal Antifungal Drug Delivery
Priscila Mazzola
Favorite
(T1030-03-16) Baru Nuts and Chia Seeds Extracts as Stabilizer in Nanostructured Formulation for Optimized Antifungal Drug Delivery of Fluconazole
Priscila Mazzola
Favorite
(T1230-01-01) Exploring Rifamycin Cytotoxic Potential in 2D and 3D Cancer Cell Models Using Liposomes as Delivery System
Priscila Mazzola
Favorite
(T1330-04-20) Unveiling the Potential of Euterpe oleraceae Mart Seed Extract: Harnessing a Valuable By-Product for Pharmaceutical and Cosmetic Innovations
Priscila Mazzola
Favorite
McAllister, Erin

Waters Corporation
(M1430-11-64) System Robustness and Best Practices of a High Throughput LC-MS Method for Cell Culture Media Nutrient and Metabolite Analysis
Erin McAllister
Favorite
(T1430-05-26) Lipid Nanoparticle Impurity Analysis: Leveraging Mass Spectrometry to Monitor Impurities and Aldehyde in Raw Materials and Formulated Drugs in Regulated Environments
Erin McAllister
Favorite
McCabe, Jacob

SCIEX
(T1330-06-33) Ultra-High Throughput HILIC-Free Analysis of Oligonucleotides Using Acoustic Ejection Mass Spectrometry
Jacob McCabe
Favorite
(T1530-10-54) High-Speed Compound Quality Assessment Using Acoustic Ejection Mass Spectrometry
Jacob McCabe
Favorite
McCalip, Andrew

Varda Space Industries
(M1230-11-62) Physical Stability of Ritonavir Crystallized in Space
Andrew McCalip
Favorite
(T1230-11-62) Chemical Stability of Ritonavir Crystallized in Space
Andrew McCalip
Favorite
(W1030-11-61) Sending Ritonavir to Space and Back – Drug Development Enabled by Specially Designed Hardware to Perform in Microgravity
Andrew McCalip
Favorite
McCarthy, Helen O.

Queen's University Belfast
(M1130-07-40) Bilayer Microneedle Array Patch for Transdermal Delivery of Novel Capsid Inhibitor Lenacapavir to Mitigate the Risk of Pediatric HIV Infection
Helen O. McCarthy
Favorite
McCartt, Daniel

Lawrence Livermore National Laboratory
(T1130-11-63) Optical Radiocarbon (¹⁴C) Tracing for Biological and Pharmaceutical Applications
Daniel McCartt
Favorite
McCorkle, Jeanette

Teva Branded Pharmaceutical Products, Inc.
(M0930-06-34) Development and Qualification of an ECLIA Method for the Detection of Fremanezumab in Human CSF
Jeanette McCorkle
Favorite
McCormick, Michael

Colorcon, Inc.
(T1130-05-26) Iron Oxides in Titanium Dioxide-Free Coatings Protect Photolabile Active Pharmaceutical Ingredients in Oral Solid Dosage Forms
Michael McCormick
Favorite
McCurdy, Christopher

University of Florida
(M1230-02-12) Metabolite Identification of a Kratom Alkaloid Speciogynine in Human Liver Microsomes and Hepatocytes
Christopher McCurdy
Favorite
(M1230-06-35) Pharmacokinetic Study of Delta-8-Tetrahydrocannabinol in Male Rats Using a Validated UPLC-MS/MS Method
Christopher McCurdy
Favorite
(M1330-02-09) Translational Pharmacokinetic Assessment of Mitragyna Speciosa (kratom), a Potential Treatment Option for Opioid Use Disorder
Christopher McCurdy
Favorite
(T1130-06-36) Synthesis and Biological Evaluation of Dual Acting Sigma Receptor Ligands and Dopamine Transporter Ligands as Potential Treatment Cocaine Misuse
Christopher McCurdy
Favorite
(W1130-02-09) Maternal Exposure to Kratom Alkaloids: A Comparative Pharmacokinetic Study of Various Kratom Preparations in Pregnant Rats
Christopher McCurdy
Favorite
McGrath, Kelly

GlaxoSmithKline plc
(W1130-02-11) Having Appropriate Critical Reagents Can Make Bi-Specific Drug Anti-Drug Antibody Assays Less Challenging and Easy to Specifically Quantify
Kelly McGrath
Favorite
McGrath, Shannon

Moderna, Inc.
(M0930-02-10) Multiplexed Cytokine Measurements in Culture Supernatants upon Ex Vivo Stimulation of Human PBMCs to Assess Cellular Immune Response in Vaccine Studies
Shannon McGrath
Favorite
(T1530-02-08) Development and Fit-for-Purpose(FFP) Validation of a 35-Color Ex Vivo Stimulation and Activation-Induced Marker (AIM) Assay to Assess Vaccine-Induced Immune Responses in Human Vaccine Trials
Shannon McGrath
Favorite
McIntyre, Kevin

International Flavors and Fragrances
(T1030-03-13) The Selection of Microcrystalline Cellulose Based Excipient in Extrusion Spheronization
Kevin McIntyre
Favorite
(T1230-05-26) Low Nitrite-Controlled Release Formulations for Water-Soluble Drugs
Kevin McIntyre
Favorite
McSweeney, Sean

Munster Technological University
(T1130-11-65) Application of Broadband Acoustic Resonance Dissolution Spectroscopy (BARDS) to Investigate Tablet Behaviour in Aqueous Media
Sean McSweeney
Favorite
Medina Monsanto, Paola

Purdue University
(T1030-11-65) Formulation in a Droplet – a Material Sparing Approach to Wet Granulation Formulation Screening
Paola Medina Monsanto
Favorite
Mehta, Dhwani

St. John's University
(W1130-04-22) Conformational Analysis of Alkyl/Aryl-α-O-Glycosides Using Isothermal Calorimetry: Stereo-Electronic Effects vs Hydrophobic Effect
Dhwani Mehta
Favorite
Mehta, Nairuti Milan

Thermo Fisher Scientific
(M0930-10-56) Evaluating Food Effects in Oral Drug Delivery Using a Combination of PBPK Modeling and Molecular Dynamics Simulations
Nairuti Milan Mehta
Favorite
Mehta, Roshani

Lonza
(M1230-07-39) A Comparative Approach in the Evaluation and Optimization of Enteric Coating for Tablet Formulation
Roshani Mehta
Favorite
Meibohm, Bernd

University of Tennessee Health Sciences Center
(M0930-03-16) Optimizing Storage Conditions to Maintain Chemical Stability and Aerodynamic Performance of Tigecycline Inhalation Powder
Bernd Meibohm
Favorite
(M1030-02-12) Investigating Differences in the Pharmacokinetics of Monoclonal Antibodies in Japanese and Non-Japanese Subjects
Bernd Meibohm
Favorite
(M1430-02-10) Population Pharmacokinetic Modeling of Time-Varying Effects of Anti-Drug Antibody Formation on the Pharmacokinetics of a Human Monoclonal Antibody in a Rodent Model
Bernd Meibohm
Favorite
Mejia, Luis

SE Tylose USA
(T1230-09-50) Downstream Processing of HPMCAS-Based Amorphous Solid Dispersion (ASD) of Fenofibrate: From Hot-Melt Extrudate to Tablet
Luis Mejia
Favorite
Mekhdjian, Armen

Gilead Sciences, Inc.
(T1430-10-58) Understanding Nitrite Loss in Pharmaceutical Drug Products and its Impact on N‑Nitrosamine Formation
Armen Mekhdjian
Favorite
Mekhssian, Kevork

Altasciences
(T1230-06-33) Development and Validation of LC-MS/MS Assay Methods to Determine Ubrogepant and Atogepant in Human Breast Milk
Kevork Mekhssian
Favorite
Melton, Kyoka

University of Texas at Austin
(M1530-10-54) Development of an Aerosolizable Dry Powder of Mycobacteriophage D29 Using Thin-Film Freeze-Drying
Kyoka Melton
Favorite
Mendonsa, Nicole

Evonik Corporation
(M1530-03-17) Downstreaming Amorphous Solid Dispersions: Direct Compression of Free-Flowing Telmisartan Microparticles
Nicole Mendonsa
Favorite
(W0930-01-05) Oral Targeting of Sensitive Microbiome: A Case from Development of Functional Coated Capsule to Clinical Trial Phase 1b
Nicole Mendonsa
Favorite
Menger, Robert

Bristol-Myers Squibb Company
(T1430-10-56) High-Throughput Analytical: Development of New High-Throughput Experimentation and Analytics Capabilities
Robert Menger
Favorite
(W1130-10-54) Streamlining Pharmaceutical Process Development: A User-Centric Approach to High-Throughput Analysis
Robert Menger
Favorite
Mengesha, Abebe

Drake University
(T1230-11-65) Epinephrine Degradation in Pediatric Auto-Injectors
Abebe Mengesha
Favorite
Meng, Fanfei

University of Massachusetts
(T1130-07-38) Deformable Polydopamine Nanocapsules for siRNA Delivery to Solid Tumors
Fanfei Meng
Favorite
Meng, Liping

Gilead Sciences, Inc.
(T1430-10-55) Manual 2D LC-MS for Peak Purity Assessment of Atropisomeric Compound
Liping Meng
Favorite
Meng, Min

Resolian
(W1030-06-32) An Electrochemiluminescence (ECL)-Based Assay for the Specific Detection of Neutralizing Anti-CAEL-01 Antibodies in Human Serum with a Pre-Treatment Procedure to Eliminate Therapeutic Drug
Min Meng
Favorite
Meng, Tuo

Virginia Commonwealth University
(T1430-07-41) Fenofibrate Microparticles for Long Lasting Therapy of Posterior Eye Disease
Tuo Meng
Favorite
Meng, Xin

Kanwhish Biotech Co.
(M1330-06-36) Establishment of an Immunoassay to Quantify Total TL1α Target in Monkey Serum Samples
Xin Meng
Favorite
Menon, Sreejit

Croda Inc.
(W0930-09-48) Impact of Excipient Purity on the Stability of Chemotherapy Drugs
Sreejit Menon
Favorite
Menon, Sreelakshmi

Mercer University
(M0930-04-20) An Innovative Dual Action Antibiotic Adjuvant Strategy Using Ionic Liquid toward Synergistic Restoration of Activity in MDRO and Enhancing Antimicrobial Activity Against MRSA
Sreelakshmi Menon
Favorite
(M1030-04-24) Old Dog Learning a New Trick: Statins as Novel Inhibitors of Vascular PDE1A for Regulating Vasodilation and Blood Pressure
Sreelakshmi Menon
Favorite
Merchant, Jumana

Zerion A/S
(M1530-10-58) In Vivo Bioavailability Enhancement of Abiraterone Acetate Dispersome^® Formulations
Jumana Merchant
Favorite
Merritt, Jeremy

Eli Lilly and Company
(M0930-01-06) Implementing Co-processed API to Enable High-Drug-Load Formulation for Direct Compression
Jeremy Merritt
Favorite
(T1130-10-55) Physicochemical Stability Investigation of Insulin in a Mesoporous Carrier Used for Oral Delivery
Jeremy Merritt
Favorite
Messina, Kathryn

Ashland Specialty Ingredients
(M1230-09-48) Role of Low Nitrite (LN) Excipients in Mitigating N-Nitrosamine Drug Substance-Related Impurity (NDSRI) Formation in Drug Products
Kathryn Messina
Favorite
Meyer, Tony

ICON Plc
(M1430-06-33) The Impact of Unique Stable Label Peptide Internal Standards toward Large Molecule Applications for LC-MS/MS
Tony Meyer
Favorite
Mfoafo, Kwadwo

Nova Southereastern University
(M1530-04-20) Polymer Effects on Kolliphor P407's Mucoadhesion
Kwadwo Mfoafo
Favorite
(T1030-04-20) Impact of Freeze-Thaw Cycles on Kolliphor P407's Thermogelling and Mucoadhesion
Kwadwo Mfoafo
Favorite
Mhatre, Susmit

Creighton University
(T1530-04-22) A Novel Hybrid Gasotransmitter for an Unmet Need of Glaucoma Therapy: A Proof-of-Concept Study
Susmit Mhatre
Favorite
Miao, Danielle

IMCD
(T1130-03-15) Investigations on Formulation and Process Effects on Avicel^® RC-591 Rheological Performance in Suspensions
Danielle Miao
Favorite
Michon, Josee

Altasciences
(T1230-06-33) Development and Validation of LC-MS/MS Assay Methods to Determine Ubrogepant and Atogepant in Human Breast Milk
Josee Michon
Favorite
Midde, Krishna

PPD Laboratories
(M1130-06-34) Comparison of Platform Sensitivities: Correlation of Endogenous Neurofilament-Light Chain Concentration Determination in Human Serum and K₂EDTA Plasma across Immunoassay Platforms
Krishna Midde
Favorite
Miezeiewski, Blair

Pharmaron (Exton) Lab Services LLC
(T1030-02-08) The Potential of In Vitro Dissolution Absorption System 2 (IDAS2) as a Bioequivalence Decision Tool
Blair Miezeiewski
Favorite
Migliore, Mattia

Massachusetts College of Pharmacy and Health Sciences
(T1530-06-33) PAR-1 Selective Antagonist, SCH-79797 Dihydrochloride, Inhibits the Proliferation and Migration of the Metastatic Human Prostate Cancer (PC-3) Cells
Mattia Migliore
Favorite
Mihailescu, Ella

Institute for Bioscience and Biotechnology Research
(T1030-01-02) Development of Novel Ionizable Lipid Nanoparticles for Enhanced siRNA Delivery
Ella Mihailescu
Favorite
Miller, Dave

AustinPx
(M1530-09-50) Exploring Manufacturing Techniques for Enhancing the Solubility of Fenbendazole: A Comparative Study of Hot-Melt Extrusion, Spray Drying, and KinetiSol® Processing
Dave Miller
Favorite
Miller, Dustin

Eli Lilly and Company
(W0930-10-55) Development of a Sensitive, Drug Tolerant Total Antibody Assay for the Detection of Antibodies against a Novel Capsid AAVPRV in Human Serum and CSF
Dustin Miller
Favorite
Miller, Kimberly

Solid State Pharma Inc.
(W1230-04-22) Assessment of High Throughput Salt Screening Methodologies with Zwitterionic Compounds
Kimberly Miller
Favorite
Milller, Victoria

Allumiqs
(T1130-06-31) ML-Driven Multi-Omics Analysis of Platelet-Rich Plasma: Differentiating Age-Related Biomarkers in Young and Old Individuals
Victoria Milller
Favorite
Minami, Kentaro

University of Miyazaki Hospital
(M1130-04-22) DEC2 Enhancement of Gemcitabine and Oxaliplatin Sensitivity of Pancreatic Cancer Cells through Suppression of IGFBP4
Kentaro Minami
Favorite
Minatovicz, Bruna

Janssen Research & Development, LLC
(M1230-10-58) Using AI-ML Modelling to Predict the Thawing Rates of Large Scale Frozen Protein Solutions
Bruna Minatovicz
Favorite
Min, Paul

Mayo Clinic
(W1230-04-24) Disruptions in Glucose and Amyloid-Beta Transport in Mouse Models Manifesting Metabolic Syndrome
Paul Min
Favorite
Miranda, Aline

Universita Degli Studi Di Milano
(T1230-03-17) Development of Long-Acting Decoquinate Nanocrystal-Based Formulations as a Chemical Vaccine for Malaria
Aline Miranda
Favorite
Miranda-Calderon, Jorge Esteban

Metropolitan Autonomous University
(W1030-01-05) Sustainable Development of a Nanosystem for the Co-encapsulation of Apigenin and Curcumin for Pharmaceutical Applications
Jorge Esteban Miranda-Calderon
Favorite
Mirmehrabi, Mahmoud

Solid State Pharma Inc.
(W1230-04-22) Assessment of High Throughput Salt Screening Methodologies with Zwitterionic Compounds
Mahmoud Mirmehrabi
Favorite
Mishra, Abhishek

Assam Kaziranga University
(W1030-04-19) Beyond Voltage-Gated Sodium Channel (Na_v1.7): Exploring the Dual Role of GX201 and Sulfamethoxazole in Itch Management
Abhishek Mishra
Favorite
Mishra, Gyan

Aprecia Pharmaceuticals LLC
(M1030-09-51) Development of 3D Printed Oral Disintegrating Tablets of Oxcarbazepine Using Co-Processed Excipient
Gyan Mishra
Favorite
Mishra, Saurabh

SE Tylose USA
(T1230-09-50) Downstream Processing of HPMCAS-Based Amorphous Solid Dispersion (ASD) of Fenofibrate: From Hot-Melt Extrudate to Tablet
Saurabh Mishra
Favorite
Mishra, Shubham

Florida A&M University
(T1130-02-11) Cannabinoid Combination Therapy for Doxorubicin Resistant MDA-MB231: Oral Exosome Formulation Versus Parenteral Approaches
Shubham Mishra
Favorite
Misic, Zdravka

DSM-Firmenich AG
(W0930-03-14) A Journey Through the Development of Cannabidiol Solid Oral Dosage Forms: Balancing API Loading, Physico-Chemical Stability and In Vivo Pharmacokinetic Performance
Zdravka Misic
Favorite
Misra, Bishal

West Virginia University
(M1530-09-48) Dual Adjuvanted Ionizable Lipid Nanoparticles for Vaccine Delivery
Bishal Misra
Favorite
Missaghi, Shahrzad

Colorcon, Inc.
(T0930-01-05) Influence of Protective Coating on Extended-Release Pellets and Maintaining Desired Drug Release from MUPS Tablets
Shahrzad Missaghi
Favorite
Mistilis, Jessica

PATH
(M1130-07-40) Bilayer Microneedle Array Patch for Transdermal Delivery of Novel Capsid Inhibitor Lenacapavir to Mitigate the Risk of Pediatric HIV Infection
Jessica Mistilis
Favorite
Mita, Nur

Auburn University
(M1130-09-52) Inclusion Complexes of Posaconazole with Hydroxypropyl- and Sulfobutylether-β-Cyclodextrins for Intravenous Injections: Formulation and Stability Studies
Nur Mita
Favorite
(T0930-03-13) Comprehensive Study on Injectable Capsaicin In Situ Forming Implant for Ultra-Long-Acting Anti-Obesity: Formulation, Characterization, Drug Release, Stability, and Cytotoxicity Studies
Nur Mita
Favorite
(T1330-05-27) Co-delivery of Curcumin and Sildenafil Citrate with 3D-Printed Collagen-Chitosan Scaffolds for Enhanced Wound Healing
Nur Mita
Favorite
Mitsuhashi, Hiromi

Daiichi Sankyo Co., Ltd.
(T1230-10-54) Validation of the Potential of Oligoarginine-Linked Hyaluronic Acid as an Absorption Enhancer Through Animal Studies from Rodents to Primates
Hiromi Mitsuhashi
Favorite
Mittapelly, Naresh

Certara UK Ltd
(M1030-02-08) Mechanistic Mathematical Modeling of In Vitro Drug Release from PLGA-Based Dexamethasone Solid Implants
Naresh Mittapelly
Favorite
(T1230-02-08) Physiologically Based Pharmacokinetic Modelling of Risperidone and Its Metabolite Paliperidone PLGA Based In Situ Gel Forming Long-Acting Injectable Formulations In Vivo
Naresh Mittapelly
Favorite
Mittman, Stephanie

Genentech, Inc.
(W1230-02-12) Translational PK/PD and First-in-Human Dose Selection of a Monoclonal Antibody Targeting a Membrane Protein
Stephanie Mittman
Favorite
Miyake, Taiji

Chugai Pharmaceutical Co., Ltd.
(T1130-02-07) Novel Method of Quantitatively Predicting the Clearance of Uridine Diphosphate-Glucuronosyltransferase Substrates Using Human Liver Chimeric Mice
Taiji Miyake
Favorite
Miyata, Kohei

Adeka Co.
(T1230-10-54) Validation of the Potential of Oligoarginine-Linked Hyaluronic Acid as an Absorption Enhancer Through Animal Studies from Rodents to Primates
Kohei Miyata
Favorite
Mizoguchi, Ryo

Astellas Pharma Inc.
(T1030-10-59) Unexpected Nucleation of Amorphous Terfenadine at a Much Lower Temperature than the Glass Transition Temperature and Its Impact on Dissolution Behavior and Physical Stability
Ryo Mizoguchi
Favorite
Mizuno, Shotaro

Tokyo Medical and Dental University
(W1030-02-10) Development of a Predictive Model for Vancomycin-Associated Nephrotoxicity Using the Area under the Concentration-Time Curve of Vancomycin: A Machine Learning Analysis
Shotaro Mizuno
Favorite
Modi, Dimple

GlaxoSmithKline plc
(M1130-10-58) Mechanistic Investigation of Gamma Irradiation Effects on Physicochemical Stability of Excipients Used in Colloidal Injectable Suspensions
Dimple Modi
Favorite
Modi, Nisarg

Transdermal Research Pharm Laboratories LLC
(T0930-11-63) Solid-State NMR and FTIR Reveal Moisture-Triggered Adhesion Loss in Rotigotine Patches
Nisarg Modi
Favorite
(W0930-11-63) Improving Adhesion Evaluation of Transdermal Rotigotine Patches: Utilizing Skin-Mimicking Substrates for Accurate Assessment
Nisarg Modi
Favorite
Moge, Serena

Beam Therapeutics
(M1130-06-32) A Chilled Liquid Handler Deck Enables the Automation of Lipid LC-MS/MS Bioanalytical Assays
Serena Moge
Favorite
Mogilla, Suchitra

Duquesne University
(W0930-11-65) Transfer of a Low Dose Formulation from Batch to Continuous Manufacturing: High-Shear Wet Granulation to Continuous Twin-Screw Wet Granulation
Suchitra Mogilla
Favorite
Mogushi, Kaoru

Tokyo Medical and Dental University
(W1030-02-10) Development of a Predictive Model for Vancomycin-Associated Nephrotoxicity Using the Area under the Concentration-Time Curve of Vancomycin: A Machine Learning Analysis
Kaoru Mogushi
Favorite
Mohamed, Eman

Texas A&M University
(M1430-05-30) Formulation Development of PEGylated Deferoxamine Carbon Nanoparticles Gel for Topical Application
Eman Mohamed
Favorite
(T1130-10-59) Quality Assessment of Four FDA-Approved Extended-Release Products of Divalproex
Eman Mohamed
Favorite
Mohamed, Esraa

University of Iowa
(T0930-09-48) Cationic CaMKIIN-Loaded Liposomes that Reduce Chlorine-Induced Airway Oxidative Stress
Esraa Mohamed
Favorite
Mohammad Gholizadeh, Amir

University of Houston
(T1030-06-35) A Validated LC-MS/MS Assay for the Simultaneous Determination of Nebivolol, Dasatinib and Devimistat and Its Application to Pharmacokinetic Study in Rats
Amir Mohammad Gholizadeh
Favorite
Mohammad, Jiyan

North Dakota State University
(W1030-07-39) Mesenchymal Stem Cell-Based Combination Therapy for Enhanced Efficacy Against Patient-Derived Lung Cancer Xenograft Model
Jiyan Mohammad
Favorite
(W1230-01-06) Peptide Conjugated Hypoxia-Responsive Nanoparticles to Decrease Triple-Negative Breast Cancer Stemness in a Patient-Derived Xenograft Mice Model
Jiyan Mohammad
Favorite
Mohammed, Yousuf

University of Queensland
(M0930-11-62) Topical Creams Sensorial Perception: Correlation with Product Critical Quality Attributes
Yousuf Mohammed
Favorite
(M1230-06-34) Influence of Quantitative Differences in Propylene Glycol on the Performance of Diclofenac Sodium Topical Gels
Yousuf Mohammed
Favorite
(T1330-07-37) Assessing the Influence of Quantitative Differences in Propylene Glycol on the Performance of Metronidazole Topical Gels
Yousuf Mohammed
Favorite
(W1130-09-48) Comparing the Performance of Metronidazole Topical Gels with Variant Concentrations of Polyethylene Glycol (PEG) 400 in the Formulation
Yousuf Mohammed
Favorite
Mohanty, Rashmi

University of Texas at Austin
(M1030-03-13) Cationic Peptide Anchor-Mediated Binding to Tumor Extracellular Matrix Improves Intratumoral Retention of Agonist CD40 Antibody
Rashmi Mohanty
Favorite
Mohiti-Asli, Mahsa

BASF Corporation
(T1530-07-38) Poloxamer 188 Variant for the Formulation of Biologics
Mahsa Mohiti-Asli
Favorite
(W1130-11-63) A New Shear Protectant: Introducing Kolliphor^® P188 Cell Culture
Mahsa Mohiti-Asli
Favorite
Mohs, Aaron

University of Nebraska Medical Center
(T1330-04-22) Exploring the Synergistic Potential of Fatty Acid Synthase Inhibitors and Geranylgeranyl Diphosphate Synthase Inhibitors in Myeloma Therapy
Aaron Mohs
Favorite
Mohurle, Swapnil

Gattefosse India Pvt., Ltd.
(T1130-01-05) Platform Technology for Introducing Liquid Solubilisers in Tablet Formulations
Swapnil Mohurle
Favorite
Mokashi, Meghana

St. John's University
(W1030-05-28) Liposomal Amodiaquine for Localized Therapy of Non-Small Cell Lung Cancer (NSCLC)
Meghana Mokashi
Favorite
Mok, Heeyoun

Dong-A ST
(M1130-01-02) Preparation and Evaluation of Pramipexole Transdermal Patch: In Vitro and In Vivo Study
Heeyoun Mok
Favorite
Momin, Mohammad

Virginia Commonwealth University
(W1030-01-04) In Vitro Characterization and In Vivo Efficacy Study of a 2nd Generation Synthetic Lung Surfactant (SLS) Excipient Enhanced Growth (EEG) Dry Powder Formulation and Device
Mohammad Momin
Favorite
Monirvaghefi, Atefeh sadat

University of Nebraska Medical Center
(M1230-01-06) Development of Inhalable CXCR4 Targeted Polymeric Nanoemulsions for Delivery of RNAi Therapeutics to Enhance Anti-PD-L1 Immunotherapy in Lung Tumors
Atefeh sadat Monirvaghefi
Favorite
Monpara, Jasmin

Philadelphia College of Pharmacy
(M1430-04-20) Coarse-Grained Molecular Dynamics Simulations Evaluating Formation and Structural Stability of Nystatin-Loaded DOPC and DPPC Vesicles
Jasmin Monpara
Favorite
(M1530-06-34) Molecular Dynamics Study Using Coarse-Grained Simulation with Martini Force Field for Structural Stability and Formation of Docetaxel Loaded DOPC and DPPC Lipid Vesicle
Jasmin Monpara
Favorite
Monrreal, Luis

Universidad de Valparaiso
(M1030-04-23) Formulation of a Triple-Action Nanoemulgel for Mild to Moderate Atopic Dermatitis: Impact on Skin's Mechanical and Antibacterial Properties
Luis Monrreal
Favorite
(M1230-09-50) The Hidden Potential: Enhancing Doxycycline Dissolution and Aerodynamics with HPMC and Gelatin for Pulmonary Drug Delivery
Luis Monrreal
Favorite
Montalbano, Nick

Seran Bioscience
(M1330-07-41) Manufacturing and Formulation Impacts on Colloidal Speciation in ASD Dosage Forms
Nick Montalbano
Favorite
Moon, Chaeho

University of Texas at Austin
(T1230-10-55) The Influence of Combined Deaeration and Polysorbate 80 on IgG Denaturation during Thin-Film Freeze-Drying
Chaeho Moon
Favorite
Moore, Erik

Creighton University
(M1230-06-33) Evaluation of Anti-Proliferative Effect of Vorinostat (a pan-HDAC Inhibitor) on Glioblastoma Multiforme Using 3-D Cell Culture Model of T98G
Erik Moore
Favorite
(T0930-05-29) Pulmonary Delivery of mRNA via Engineered Chitosan Nanoparticles: Development and Application
Erik Moore
Favorite
(T1030-01-03) Chitosan DNA Nanoparticle for PRPF31 Gene Delivery in Retinal Cell Line: Formulation and Characterization
Erik Moore
Favorite
Moore, Jodi

Moderna, Inc.
(T1530-02-08) Development and Fit-for-Purpose(FFP) Validation of a 35-Color Ex Vivo Stimulation and Activation-Induced Marker (AIM) Assay to Assess Vaccine-Induced Immune Responses in Human Vaccine Trials
Jodi Moore
Favorite
Moraga-Espinoza, Daniel

Universidad de Valparaiso
(M1030-04-23) Formulation of a Triple-Action Nanoemulgel for Mild to Moderate Atopic Dermatitis: Impact on Skin's Mechanical and Antibacterial Properties
Daniel Moraga-Espinoza
Favorite
(M1230-09-50) The Hidden Potential: Enhancing Doxycycline Dissolution and Aerodynamics with HPMC and Gelatin for Pulmonary Drug Delivery
Daniel Moraga-Espinoza
Favorite
Morales‑Cummings, Nadya

BASF Corporation
(W1130-11-63) A New Shear Protectant: Introducing Kolliphor^® P188 Cell Culture
Nadya Morales‑Cummings
Favorite
Morales-Ibarria, Marcia

Metropolitan Autonomous University
(M1330-03-17) Development, Characterization, and In Vitro Digestion of C-phycocyanin-Whey Protein Isolate-Zein Nanoparticles for Pharmaceutical Applications
Marcia Morales-Ibarria
Favorite
Morales, Javier

Universidad de Chile
(M1230-09-50) The Hidden Potential: Enhancing Doxycycline Dissolution and Aerodynamics with HPMC and Gelatin for Pulmonary Drug Delivery
Javier Morales
Favorite
(M1330-09-51) Synthesis and Characterization of Nanostructured Lipid Carriers (NLC) with Bile Salts: Sodium Deoxycholate (SDC), Sodium Deoxyglycholate (SDGC) and Sodium Deoxytaurocholate (SDTC)
Javier Morales
Favorite
Moravcevic, Katarina

Janssen Research & Development, LLC
(W1030-11-65) Vicious Variability: Capillary Isoelectric Focusing Method Performance Issues with Non-Detergent Sulfobetaine 211 as an Additive
Katarina Moravcevic
Favorite
Moreira, Diogo

Fiocruz
(T1230-03-17) Development of Long-Acting Decoquinate Nanocrystal-Based Formulations as a Chemical Vaccine for Malaria
Diogo Moreira
Favorite
Moreno-Castellanos, Natalia

Universidad Industrial de Santander
(W1130-03-14) Microarray Patches with Cyclodextrin-Carvedilol Complex for Heart Failure Treatment
Natalia Moreno-Castellanos
Favorite
Morimoto, Yasuaki

Freund Corporation
(M1130-10-57) Evaluation of Lubricant Distribution in Tablets Using All-in-One Excipients
Yasuaki Morimoto
Favorite
(T1430-10-59) Enhanced Versatility of a Novel Coating Methods of Fine Particles for Time-Saving
Yasuaki Morimoto
Favorite
Morita, Keiichi

Chugai Pharmaceutical Co., Ltd.
(T1130-02-07) Novel Method of Quantitatively Predicting the Clearance of Uridine Diphosphate-Glucuronosyltransferase Substrates Using Human Liver Chimeric Mice
Keiichi Morita
Favorite
Morker, Krupal

Frontage Laboratories, Inc.
(W0930-03-13) Evaluating the Feasibility of Lyophilization for Oral Formulation Development of Monoclonal Antibodies (mAbs)
Krupal Morker
Favorite
Morrison, Ryan

Inotiv, Inc.
(T1230-06-31) A Technical Evaluation of Targeted Protein Quantification in Formalin Fixed Paraffin Embedded Tumor Sections by Mass Spectrometry Including Antibody Drug Conjugates (ADC)
Ryan Morrison
Favorite
Mortada, Ahmed

University of Mississippi
(M1430-09-50) Creating Personalized 3D-Printed Finger Splints with Ibuprofen-Loaded Nanofibers for Quicker Healing Using CT Scans
Ahmed Mortada
Favorite
(W1230-09-49) Optimization of Ocular Mini Tablet Formulations: A Comparative Study of 3D FDM Printing and Vacuum Compression Molding Methods for Sustained Drug Release
Ahmed Mortada
Favorite
Mort, Paul

Purdue University
(T1030-11-65) Formulation in a Droplet – a Material Sparing Approach to Wet Granulation Formulation Screening
Paul Mort
Favorite
(T1430-11-64) Reducing Cycle Time While Maintaining Acceptable Granule and Tablet Properties for a Semi-Continuous Fluidized Bed Granulation Process
Paul Mort
Favorite
Mosharraf, Mitra

Engimata
(M1430-11-60) Characterization of Protein Antigens in Liposomal Vaccines Using Differential Scanning Fluorimetry
Mitra Mosharraf
Favorite
(W1030-03-16) Predicting the Aggregation Behavior of Liposomes Using Thermal Analysis
Mitra Mosharraf
Favorite
Mosley-Kellum, Keb

Florida A&M University College Of Pharmacy & Pharmaceutical Sciences - Tallahass
(T0930-11-63) Solid-State NMR and FTIR Reveal Moisture-Triggered Adhesion Loss in Rotigotine Patches
Keb Mosley-Kellum
Favorite
(W0930-11-63) Improving Adhesion Evaluation of Transdermal Rotigotine Patches: Utilizing Skin-Mimicking Substrates for Accurate Assessment
Keb Mosley-Kellum
Favorite
Mosquera-Giraldo, Laura I.

Bristol-Myers Squibb Company
(M1430-05-25) Hydrolysis of Cellulose Acetate Phthalate and Hydroxypropyl Methylcellulose Phthalate in Amorphous Solid Dispersions
Laura I. Mosquera-Giraldo
Favorite
(T1530-10-57) Impact of Counterions on the Performance of Spray-Dried Dispersions of Weak Base Drugs
Laura I. Mosquera-Giraldo
Favorite
Mostafa, Nourhan

University of Mississippi
(T1530-01-03) Influence of Composition Variation on Solubility and Release Profile of CBD Self-Emulsifying Drug Delivery System
Nourhan Mostafa
Favorite
(W1230-03-17) Optimizing the Process Parameters for Utilizing Hot-Melt Extrusion Technology in the Development of Cannabidiol Nano-Structured Lipid Carriers
Nourhan Mostafa
Favorite
Mostofa, Agm

US Food and Drug Administration
(M1430-02-07) An Overview of Cross-Referencing Approaches to Support Generic Drug Approval
Agm Mostofa
Favorite
Mota, Rute

Hovione PharmaScience SA
(T0930-05-27) Improving Lipid Nanoparticles Stability for mRNA Lung Delivery Through Nebulization
Rute Mota
Favorite
Mousa, Youssef

US Food and Drug Administration
(T1230-04-23) PBPK Modeling to Predict the Effect of Gastric pH on Bioequivalence of Dabigatran Etexilate Capsules
Youssef Mousa
Favorite
Moustafa, Tarek

University of Utah
(W0930-04-19) Quantitative Phase Imaging for Evaluation of the Radioprotective Effects of Synthetic Glycosaminoglycans on Immune Cells
Tarek Moustafa
Favorite
Mrsny, Randy

University of Bath
(T1030-07-38) SubQ Environment Impact on In Vitro Drug Release of PLGA Microspheres
Randy Mrsny
Favorite
M, Ruthvija

Malla Reddy College of Pharmacy
(W1230-03-15) Preparation of Lurasidone Hydrochloride Nanoparticles and Enhanced Bioavailability
Ruthvija M
Favorite
Mudalige, Thilak

US Food and Drug Administration
(T0930-11-61) Elevating Liposomal Formulation Analysis: An Advanced CE-C4D Method for Quantification of Ionic Excipients in Liposomal Doxorubicin
Thilak Mudalige
Favorite
(T1030-11-61) Comprehensive Composition Analysis of Doxorubicin HCl Liposomes
Thilak Mudalige
Favorite
(W0930-11-61) Quantitative and Qualitative Analysis of Lipids and Cholesterol Derivatives in SMOF Lipids 20% Intravenous Lipid Emulsion
Thilak Mudalige
Favorite
Muddineti, Omkara

Nexus Pharmaceuticals LLC
(M1530-09-51) Influence of Lyophilization Process Conditions on Crystallization Behavior and Formulation Stability of Doxycycline for Injection
Omkara Muddineti
Favorite
Mueller-Albers, Jessica

Evonik Nutrition & Care GmbH
(M1530-03-17) Downstreaming Amorphous Solid Dispersions: Direct Compression of Free-Flowing Telmisartan Microparticles
Jessica Mueller-Albers
Favorite
Muhindo, Derick

Bayer Consumer Care
(M0930-03-14) Styl’One Nano Compaction Simulation Studies and Utilization of a Digital Tableting Platform in Formulation Development
Derick Muhindo
Favorite
Mukhopadhyay, Sushobhan

University of Florida
(M1230-02-12) Metabolite Identification of a Kratom Alkaloid Speciogynine in Human Liver Microsomes and Hepatocytes
Sushobhan Mukhopadhyay
Favorite
(M1230-06-35) Pharmacokinetic Study of Delta-8-Tetrahydrocannabinol in Male Rats Using a Validated UPLC-MS/MS Method
Sushobhan Mukhopadhyay
Favorite
(M1330-02-09) Translational Pharmacokinetic Assessment of Mitragyna Speciosa (kratom), a Potential Treatment Option for Opioid Use Disorder
Sushobhan Mukhopadhyay
Favorite
(W1130-02-09) Maternal Exposure to Kratom Alkaloids: A Comparative Pharmacokinetic Study of Various Kratom Preparations in Pregnant Rats
Sushobhan Mukhopadhyay
Favorite
Muley, Sheetal

Experic
(W0930-01-04) Optimizing Drum Selection for Volumetric-Based Capsule Filling: A Mechanistic Model for Lactose-Based Formulations
Sheetal Muley
Favorite
Mulherin, Kevin

Corium Innovations
(T1530-01-06) Use of In Silico Models to Predict In Vitro Skin Flux and Comparison with Experimental Results for Transdermal Drug Delivery
Kevin Mulherin
Favorite
Mullin, James

Simulations Plus, Inc.
(T0930-09-51) Enhanced PBPK-Based In Vitro to In Vivo Extrapolation Method to Support the Development of Pulmonary Drug Products
James Mullin
Favorite
Munasinghe, Indeewara

University of Kansas
(T1030-09-50) Amorphous Solid Dispersions of Spray Dried Celecoxib-SBE7βCD-Polymer Ternary Complexes: Enhancements on Intrinsic Dissolution, Crystallization Prevention, and Stabilizing Effects.
Indeewara Munasinghe
Favorite
Munira, Sirazum

University of Alberta
(W1230-01-03) Cellular Uptake of Bare and Corona Coated PEO-b-PCL and PEO-b-PBCL Micelles by HCT116 and SW620 Cell Lines
Sirazum Munira
Favorite
Munjoma, Nyasha

Waters Corporation
(M1330-06-33) Plasma and Liver Pharmacolipidodynamics of Gefitinib after Intravenous Administration to Mice Using LC-MS/MS and MS Imaging
Nyasha Munjoma
Favorite
Munnangi, Siva Ram

University of Mississippi
(M1430-05-29) Addressing the Opioid Crisis: Assessing Abuse-Deterrent Formulations Utilizing Ion-Exchange Resin Complexation Processed via Twin-Screw Granulation for Improved Safety and Effectiveness
Siva Ram Munnangi
Favorite
(M1430-05-29) Addressing the Opioid Crisis: Assessing Abuse-Deterrent Formulations Utilizing Ion-Exchange Resin Complexation Processed via Twin-Screw Granulation for Improved Safety and Effectiveness
Siva Ram Munnangi
Favorite
Munnangi, Sivaram

University of Mississippi
(T1530-01-04) Evaluation of Process Parameters for Continuous Manufacturing of Quetiapine Fumarate Immediate Release Tablets Using Twin Screw Wet Granulation
Sivaram Munnangi
Favorite
Munoz, Eric

Resolian
(W1030-06-32) An Electrochemiluminescence (ECL)-Based Assay for the Specific Detection of Neutralizing Anti-CAEL-01 Antibodies in Human Serum with a Pre-Treatment Procedure to Eliminate Therapeutic Drug
Eric Munoz
Favorite
Munroe, David

Adare Pharmaceuticals, Inc.
(W1030-01-01) Nitrosamine Mitigation Case Study: The Importance of Utilizing a Multi-Pronged Approach to Reduce Impurities
David Munroe
Favorite
Munshi, Utpal

US Food and Drug Administration
(M1530-04-23) Deciphering Sub-Therapeutic Risks: Integrating In Vitro Release and Modeling for Lamotrigine Extended-Release Tablets
Utpal Munshi
Favorite
(W1230-02-11) Risk Assessment for Extrapolation of Bioequivalence Conclusion from a Male-Only Study Population to the General Population
Utpal Munshi
Favorite
Munson, Eric

Purdue University
(M0930-11-60) Improving the Stability of RNA Lipid Nanoparticles Using the Innovative Spray-Freeze Drying Technique
Eric Munson
Favorite
(M1330-05-30) Investigating Partial Trehalose Crystallization During Lyophilization of Proteins
Eric Munson
Favorite
Munson, Eric

Kanas Analytical Services, LLC
(M1530-11-63) Safe and Effective Analysis of High Potency Compounds Using Solid-State NMR Spectroscopy
Eric Munson
Favorite
Munson, Eric

Purdue University
(T1130-11-60) Investigating the Impact of Drying Processes on RNA Lipid Nanoparticles
Eric Munson
Favorite
(T1430-11-60) Determining Impact of Particle Size and Crystal Quality on Formation of Nitrosamine in API and Drug Formulations
Eric Munson
Favorite
(T1530-11-63) Development of the USP Chapter < 1762 > for Solid-State Nuclear Magnetic Resonance Spectroscopy
Eric Munson
Favorite
(W1230-07-41) Novel Inter-Polymer Complexes in the Development of Spray-Dried Dispersions: A Computational and Experimental Study
Eric Munson
Favorite
(W1230-11-65) Effect of Lyophilization Process Parameters on the Stability of mRNA Lipid Nanoparticles (LNP)
Eric Munson
Favorite
Muolokwu, Chinenye

North Dakota State University
(T1130-04-21) Plasmid ApoE2 Gene Delivery Across the Blood Brain Barrier for the Treatment of Alzheimer's Disease
Chinenye Muolokwu
Favorite
Mu, Qingxin

University of Washington
(W1230-10-58) A Stable and Scalable Gemcitabine and Paclitaxel Drug Combination Nanoparticle (DcNP) Exhibits Long-Acting Pharmacokinetics and Breast Tumor Regression in an Orthotopic 4T1 Mouse Model
Qingxin Mu
Favorite
Murazumi, Yasuhiro

Dalton Corporation
(W0930-11-65) Transfer of a Low Dose Formulation from Batch to Continuous Manufacturing: High-Shear Wet Granulation to Continuous Twin-Screw Wet Granulation
Yasuhiro Murazumi
Favorite
Murira, Armstrong

Simmunome Inc.
(M1130-02-09) Deciphering Response Patterns to AKT Inhibitor MK2206 in Breast Cancer Patients: Unveiling Signature Profiles
Armstrong Murira
Favorite
(T1130-06-31) ML-Driven Multi-Omics Analysis of Platelet-Rich Plasma: Differentiating Age-Related Biomarkers in Young and Old Individuals
Armstrong Murira
Favorite
Murlidharan, Nanditha

University of Maryland Baltimore
(M1430-03-18) Optimizing Semi-Solid Extrusion 3D Printed Hydrochlorothiazide Tablets: The Role of Rheological Properties and Drying Methods on Structure and Appearance
Nanditha Murlidharan
Favorite
(T1330-11-61) NIR-Based Quality Analytics for Semisolid Extrusion 3D Drug Printing
Nanditha Murlidharan
Favorite
Murphy, Liam

Moderna, Inc.
(T1530-02-08) Development and Fit-for-Purpose(FFP) Validation of a 35-Color Ex Vivo Stimulation and Activation-Induced Marker (AIM) Assay to Assess Vaccine-Induced Immune Responses in Human Vaccine Trials
Liam Murphy
Favorite
Murphy, Thomas

WuXi AppTec Co., Ltd.
(M1030-04-21) Overexpression of Human ApoC3 in Mice Leads to Hypertriglyceridemia and Induces Key CVD-related Lipid Biomarkers
Thomas Murphy
Favorite
Murray, Jack

University College Cork
(T1130-06-33) Investigating the Modelability of Human Oral Fraction Absorbed using Regulatory Data
Jack Murray
Favorite
Murry, Daryl

University of Nebraska Medical Center
(T1130-05-28) ROS-Responsive Polymeric Chloroquine Nanogel as Oral Maintenance Therapy for Inflammatory Bowel Disease
Daryl Murry
Favorite
Murshed, Mubtasim

University of Bath
(T1130-09-50) Biopharmaceutical Tools for De-risking Paediatric Formulation Development
Mubtasim Murshed
Favorite
Murthy, Reena

Topical Products Testing
(M1530-06-35) Formulation and Evaluation of Antibacterial Activity of K21 Topical Liquid and Gel Formulations
Reena Murthy
Favorite
Murthy, S.Narasimha

Topical Products Testing
(M1230-06-34) Influence of Quantitative Differences in Propylene Glycol on the Performance of Diclofenac Sodium Topical Gels
S.Narasimha Murthy
Favorite
(M1530-06-35) Formulation and Evaluation of Antibacterial Activity of K21 Topical Liquid and Gel Formulations
S.Narasimha Murthy
Favorite
(T1330-07-37) Assessing the Influence of Quantitative Differences in Propylene Glycol on the Performance of Metronidazole Topical Gels
S.Narasimha Murthy
Favorite
(W1130-09-48) Comparing the Performance of Metronidazole Topical Gels with Variant Concentrations of Polyethylene Glycol (PEG) 400 in the Formulation
S.Narasimha Murthy
Favorite
(W1230-10-55) In Vivo Evaluation of Cocoyl Caprylocaprate on API Skin Permeation and Bioavailability
S.Narasimha Murthy
Favorite
Mustafa, Bahaa

University of Arkansas for Medical Sciences
(M1430-04-21) Anti-CD47 Peptide Combined with Oncolytic Vesiculovirus-Driven Intratumoral Immunotherapy for Colorectal Cancer
Bahaa Mustafa
Favorite
Muste, Cathy

Biogen
(W1030-06-35) Pharmacologically Active Drug Metabolites: Impact on Drug Discovery
Cathy Muste
Favorite
Musuku, Adrien

Pharmascience Inc.
(M1330-06-34) Use of Derivatization for a Sensitive and Selective Liquid Chromatography–Mass Spectrometry Method for Quantification of Acetaldehyde in Plasma
Adrien Musuku
Favorite
Muttavarapu, Ramesh

Thermo Fisher Scientific
(M0930-01-03) Overcoming Direct Compression Issues in Omeprazole Formulations Using Co-Processed Excipient vs. Wet Granulation
Ramesh Muttavarapu
Favorite
(M1530-10-56) Enhancing the Solubilization and Permeation of Fenofibrate: A Comparative Study of Free Form, PEG and SEDDS Formulations
Ramesh Muttavarapu
Favorite
(W1230-10-56) Efficient Manufacturing of Omeprazole Modified-Release Minitablets Using “All-in-One” Co-Processed Excipient and Talc-Free Aqueous Coating System
Ramesh Muttavarapu
Favorite
Mutter-Rottmayer, Liz

Genentech, Inc.
(W1230-02-12) Translational PK/PD and First-in-Human Dose Selection of a Monoclonal Antibody Targeting a Membrane Protein
Liz Mutter-Rottmayer
Favorite
Muturi, Harrison

Labcorp
(M0930-10-59) Validation of a Quantitative PCR (qPCR) Assay for the Detection and Quantification of Replication Competent Lentivirus for Patient Monitoring in Lentiviral Vector-Based Cell Therapy Studies
Harrison Muturi
Favorite
Mutylo, Elizaveta

University of Chemistry and Technology
(M1030-11-61) Capsule Customization: Pioneering Automated Production of Patient-Specific Poly-Pills
Elizaveta Mutylo
Favorite
(T0930-05-28) Nanoscale Catch-and-Release - Development of Redispersing Solid Nanocrystalline Drug Forms
Elizaveta Mutylo
Favorite
Muzaffar, Suhail

University of Alabama at Birmingham
(M1030-05-28) In Vitro and In Vivo Evaluation of Topical 4-phenylbutyric Acid Microsponge Formulation as a Potential Antidote Against Arsenical-Induced Skin Injury
Suhail Muzaffar
Favorite
Myratgeldiyev, Gadam

University of Kentucky
(T1030-04-23) Clinical Potential of UK4b as a New Generation of Anti-Inflammatory Drug to Treat Pain and Arthritis
Gadam Myratgeldiyev
Favorite
Myslitska, Daria

Physiolution Polska sp. z o. o.
(M0930-02-09) Predicting Bioequivalence with the COMPASS Tool - Analysis of the Experimental and Literature Data
Daria Myslitska
Favorite
(W1130-01-03) Simulation of Variable Fasted Gastric Motility and pH as a Key to Understand Contrasting Properties of Immediate Release Pellet-Filled Capsules and Bare Pellets
Daria Myslitska
Favorite
Myung, Ja Hye

US Food and Drug Administration
(M1030-06-34) In Vitro Permeation Test Outlier Data Evaluation during Bioequivalence Assessment of Abbreviated New Drug Applications
Ja Hye Myung
Favorite